Continental Postal Services of Hebland

SpaceX proxy investors want out. They may not have a choice

When SpaceX confirmed its IPO plans in December 2025, retail investors who could not access pre-IPO allocations moved fast. They poured money into every fund and ETF that held any SpaceX exposure they could find. The Destiny Tech100 Fund surged 27 percent. The Tema Space Innovators ETF tripled its assets to roughly $1.3 billion in a single week. The ERShares Private-Public Crossover ETF watched SpaceX balloon to 23 percent of its total assets. A net $14 billion flowed into proxy funds between December and May.

Now, with the roadshow beginning June 4 and Nasdaq trading expected under the ticker SPCX on June 12, some of those same investors want out. And they may not have a choice.

The Sydney Morning Herald, citing industry analysts and fund observers, reported this week that the SpaceX IPO is creating distortions in the proxy fund market that are making it difficult for investors to exit at fair value before the actual stock becomes tradeable. The problem has several dimensions.

First, the proxy funds themselves carry structural constraints. Closed-end funds like Destiny Tech100 cannot issue or redeem shares on demand. Their share prices can trade at significant premiums or discounts to net asset value depending on investor sentiment, meaning an investor who bought at a premium to NAV during the December excitement may now be sitting on a far smaller gain than the underlying SpaceX valuation increase would suggest, or even a loss if the premium has compressed.

Second, the ETFs that accumulated SpaceX exposure through special-purpose vehicles face liquidity mismatches. SpaceX shares in those vehicles are illiquid private company equity. The ETFs themselves are liquid and trade daily. When investor sentiment shifts and selling pressure builds, fund managers must manage that mismatch, either by selling other liquid assets, borrowing against their holdings, or suspending redemptions in extreme scenarios. None of those outcomes are what investors chasing SpaceX momentum had in mind when they rushed into these structures.

Third, the distortion works in both directions. Funds that have become heavily concentrated in SpaceX exposure, in some cases like ERShares representing nearly a quarter of total assets, are now effectively single-stock bets on an IPO outcome rather than diversified investment vehicles. Investors who bought those funds for diversification got something rather different from what the label described.

Gemma Dale, director of SMSF and investor behaviour at Australian online trading platform Nabtrade, said investors are wary that the SpaceX IPO could distort valuations across the proxy fund market, because once the actual stock trades freely, the premium that proxy funds commanded by offering the only accessible exposure to SpaceX will compress or disappear. At that point, the investors who paid the most for proxy access could find themselves holding something worth considerably less than the IPO price suggests.

The broader concern is a version of the same dynamic that has played out in every high-profile IPO where demand for pre-IPO access creates satellite markets. The satellite markets price in enormous optimism. The actual IPO prices at a more rational level. The gap between the two is paid by whoever is holding the proxy exposure when the real stock starts trading.

SpaceX has reduced its target IPO valuation from above $2 trillion to at least $1.8 trillion, following a $4.28 billion net loss in the first quarter of 2026 driven by AI infrastructure costs from its February merger with xAI, Elon Musk’s artificial intelligence company. Prediction market traders on Polymarket give 63 percent odds that the stock closes its first trading day above $2.2 trillion, suggesting the market still expects a significant premium to the filing target. Whether that premium materialises will determine whether the proxy fund investors who stayed were right to hold, or whether the exits they could not find would have served them better.

The roadshow begins June 4. Pricing is expected around June 11. SPCX begins trading June 12. Investors who have been trying to get out before that date are running out of time.

Crédito: Link de origem

Leave A Reply

Your email address will not be published.